학술논문
Review of 90 Y-ibritumomab tiuxetan as first-line consolidation radio-immunotherapy for B-cell follicular non-Hodgkin's lymphoma.
Document Type
Article
Author
Source
Cancer Management & Research; 2009, Vol. 1, p131-136, 6p
Subject
Language
ISSN
11791322